Drusen Secondary to Age-Related Macular Degeneration

  • Karen B. Schaal
  • Philip J. Rosenfeld


Drusen are one of the earliest signs of age-related macular degeneration (AMD) and are important for assessing disease progression and for the staging of disease severity. SD-OCT imaging is currently the most reliable strategy for following drusen morphology and progression over time, and SD-OCT imaging has replaced color fundus imaging for following drusen in clinical trials. The SD-OCT algorithm used to measure drusen defines drusen as elevations of the overlying RPE and provides both area and volume measurements. Drusen volume was found to be a more sensitive indicator of drusen growth compared with area measurements and offers an opportunity to study therapies at an earlier stage of AMD. By intervening earlier, there’s the potential to preserve better vision over a lifetime. An ideal baseline drusen volume to study in clinical trials was found to be a drusen volume of at least 0.03 mm3 (cube root volume 0.31 mm), which is easily measured by SD-OCT imaging and includes the large drusen (125 μm) that are easily seen on color fundus imaging. To determine if drusen actually grow or decrease in size, we recommend the use of the difference in cube-root of the volume measurements to evaluate the change in drusen over time.


Retinal Pigment Epithelium Geographic Atrophy Color Fundus Inner Limit Membrane Pigmentary Abnormality 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Age-Related Eye Disease Study Research G (2001) The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 132:668–681CrossRefGoogle Scholar
  2. Bartlett H, Eperjesi F (2007) Use of fundus imaging in quantification of age-related macular change. Surv Ophthalmol 52:655–671CrossRefPubMedGoogle Scholar
  3. Baumann B, Gotzinger E, Pircher M et al (2010) Segmentation and quantification of retinal lesions in age-related macular degeneration using polarization-sensitive optical coherence tomography. J Biomed Opt 15:061704CrossRefPubMedPubMedCentralGoogle Scholar
  4. Bird AC, Bressler NM, Bressler SB et al (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39:367–374CrossRefPubMedGoogle Scholar
  5. Bressler NM, Munoz B, Maguire MG et al (1995) Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol 113:301–308CrossRefPubMedGoogle Scholar
  6. Chavali VR, Diniz B, Huang J et al (2015) Association of OCT derived drusen measurements with AMD associated-genotypic SNPs in Amish population. J Clin Med 4:304–317Google Scholar
  7. Chen Q, Leng T, Zheng LL et al (2014) An improved optical coherence tomography-derived fundus projection image for drusen visualization. Retina 34:996–1005CrossRefPubMedGoogle Scholar
  8. Chew EY, Clemons TE, Agron E et al (2014) Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. JAMA Ophthalmol 132:272–277CrossRefPubMedGoogle Scholar
  9. Chiu SJ, Izatt JA, O'Connell RV et al (2012) Validated automatic segmentation of AMD pathology including drusen and geographic atrophy in SD-OCT images. Invest Ophthalmol Vis Sci 53:53–61CrossRefPubMedGoogle Scholar
  10. Cukras C, Agron E, Klein ML et al (2010) Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. Ophthalmology 117:489–499CrossRefPubMedPubMedCentralGoogle Scholar
  11. Curcio CA, Messinger JD, Sloan KR et al (2013) Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina 33:265–276CrossRefPubMedGoogle Scholar
  12. Davis MD, Gangnon RE, Lee LY et al (2005) The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 123:1484–1498CrossRefPubMedGoogle Scholar
  13. de Amorim Garcia Filho CA, Yehoshua Z, Gregori G et al (2014) Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina. 45:18–31Google Scholar
  14. Ferris FL 3rd, Wilkinson CP, Bird A et al (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844–851CrossRefPubMedGoogle Scholar
  15. Feuer WJ, Yehoshua Z, Gregori G et al (2013) Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26. JAMA Ophthalmol 131:110–111CrossRefPubMedGoogle Scholar
  16. Folgar FA, Yuan EL, Sevilla MB et al (2016) Drusen volume and retinal pigment epithelium abnormal thinning volume predict 2-year progression of age-related macular degeneration. Ophthalmology 123:39–50.e1Google Scholar
  17. Friberg TR, Huang L, Palaiou M, Bremer R (2007) Computerized detection and measurement of drusen in age-related macular degeneration. Ophthalmic Surg Lasers Imaging 38:126–134PubMedGoogle Scholar
  18. Gotzinger E, Pircher M, Geitzenauer W et al (2008) Retinal pigment epithelium segmentation by polarization sensitive optical coherence tomography. Opt Express 16:16410–16422CrossRefPubMedPubMedCentralGoogle Scholar
  19. Gregori G, Wang F, Rosenfeld PJ et al (2011) Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration. Ophthalmology 118:1373–1379PubMedPubMedCentralGoogle Scholar
  20. Gregori G, Yehoshua Z, Garcia Filho CA et al (2014) Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci 55:7662–7668CrossRefPubMedPubMedCentralGoogle Scholar
  21. Jain N, Farsiu S, Khanifar AA et al (2010) Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographs. Invest Ophthalmol Vis Sci 51:4875–4883CrossRefPubMedPubMedCentralGoogle Scholar
  22. Klein R, Davis MD, Magli YL et al (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98:1128–1134CrossRefPubMedGoogle Scholar
  23. Klein R, Klein BE, Tomany SC et al (2002) Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 109:1767–1779CrossRefPubMedGoogle Scholar
  24. Klein R, Klein BE, Knudtson MD et al (2007) Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 114:253–262CrossRefPubMedGoogle Scholar
  25. Ouyang Y, Heussen FM, Hariri A et al (2013) Optical coherence tomography-based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration. Ophthalmology 120:2656–2665CrossRefPubMedGoogle Scholar
  26. Parodi MB, Virgili G, Evans JR (2009) Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Cochrane Database Syst Rev (3):CD006537Google Scholar
  27. Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP (1999) Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br J Ophthalmol 83:358–368CrossRefPubMedPubMedCentralGoogle Scholar
  28. Schaal KB, Rosenfeld PJ, Gregori G, et al (2016) Anatomic Clinical Trial Endpoints for Nonexudative Age-Related Macular Degeneration. Ophthalmology 123:1060–79.Google Scholar
  29. Schlanitz FG, Ahlers C, Sacu S et al (2010) Performance of drusen detection by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 51:6715–6721CrossRefPubMedGoogle Scholar
  30. Schlanitz FG, Sacu S, Baumann B et al (2015) Identification of drusen characteristics in age-related macular degeneration by polarization-sensitive optical coherence tomography. Am J Ophthalmol 160:335–344.Google Scholar
  31. Smith RT, Chan JK, Nagasaki T et al (2005) A method of drusen measurement based on reconstruction of fundus background reflectance. Br J Ophthalmol 89:87–91CrossRefPubMedPubMedCentralGoogle Scholar
  32. Sparrow JM, Dickinson AJ, Duke AM et al (1997) Seven year follow-up of age-related maculopathy in an elderly British population. Eye (Lond) 11:315–324CrossRefGoogle Scholar
  33. Sugita M, Zotter S, Pircher M et al (2013) Motion artifact and speckle noise reduction in polarization sensitive optical coherence tomography by retinal tracking. Biomed Opt Express 5:106–122CrossRefPubMedPubMedCentralGoogle Scholar
  34. Wang JJ, Foran S, Smith W, Mitchell P (2003) Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol 121:658–663CrossRefPubMedGoogle Scholar
  35. Wu Z, Luu CD, Ayton LN et al (2014) Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. Ophthalmology 121:2415–2422CrossRefPubMedGoogle Scholar
  36. Yehoshua Z, Rosenfeld PJ, Gregori G, Penha F (2010) Spectral domain optical coherence tomography imaging of dry age-related macular degeneration. Ophthalmic Surg Lasers Imaging 41(Suppl):S6–S14CrossRefPubMedGoogle Scholar
  37. Yehoshua Z, Rosenfeld PJ, Gregori G et al (2011a) Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology 118:679–686CrossRefPubMedGoogle Scholar
  38. Yehoshua Z, Wang F, Rosenfeld PJ et al (2011b) Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology 118:2434–2441CrossRefPubMedPubMedCentralGoogle Scholar
  39. Yehoshua Z, Gregori G, Sadda SR et al (2013) Comparison of drusen area detected by spectral domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci 54:2429–2434CrossRefPubMedPubMedCentralGoogle Scholar
  40. Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP et al (2014) Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. Ophthalmology 121:693–701CrossRefPubMedGoogle Scholar
  41. Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP et al (2015) Comparison of geographic atrophy growth rates using different imaging modalities in the COMPLETE study. Ophthalmic Surg Lasers Imaging Retina 46:413–422CrossRefPubMedGoogle Scholar
  42. Zweifel SA, Spaide RF, Curcio CA et al (2010) Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 117:303–312.e1CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2017

Authors and Affiliations

  1. 1.Bascom Palmer Eye InstituteMiamiUSA

Personalised recommendations